An optimal ubiquitin-proteasome pathway in the nervous system: The role of deubiquitinating enzymes

Frontiers in Molecular Neuroscience

Volumn 7, Issue AUG, 2014, Pages

  Ristic, Gorica ^a   Tsou, Wei Ling ^a   Todi, Sokol V ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Glia; Neurodegeneration; Neuron; Protease; Proteasome; Synapse; Ubiquitin

Indexed keywords

ALPHA SYNUCLEIN; ATAXIN 1; ATAXIN 3; ATAXIN 7; BORTEZOMIB; CARFILZOMIB; CYSTEINE PROTEINASE; DEUBIQUITINASE; ESCRT PROTEIN; METALLOPROTEINASE; OTUBAIN PROTEASE; PROTEASOME; PROTEIN JAMM; PROTEIN P53; PROTEIN PSMD14; PROTEIN UCHL1; PROTEIN UCHL5; PROTEIN USP14; PROTEIN USP7; PROTEIN USP9X; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

CATALYSIS; ENZYME DEGRADATION; ENZYME INHIBITION; GENE SILENCING; HUMAN; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; REVIEW; SYNAPTIC TRANSMISSION; UBIQUITIN PROTEASOME PATHWAY; UBIQUITINATION; UPREGULATION;

EID: 84920999733     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00072     Document Type: Review

References (130)

1. Al-Shami, A., Jhaver, K. G., Vogel, P., Wilkins, C., Humphries, J., Davis, J. J., et al. (2010). Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development. PLoS ONE 5: e13654. doi: 10.1371/journal.pone.0013654
2. Anderson, C., Crimmins, S., Wilson, J. A., Korbel, G. A., Ploegh, H. L., and Wilson, S. M. (2005). Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 95, 724-731. doi: 10.1111/j.1471-4159.2005.03409.x
3. Athanassiadou, A., Voutsinas, G., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., et al. (1999). Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. Am. J. Hum. Genet. 65, 555-558. doi: 10.1086/302486
4. Beck, F., Unverdorben, P., Bohn, S., Schweitzer, A., Pfeifer, G., Sakata, E., et al. (2012). Near-atomic resolution structural model of the yeast 26S proteasome. Proc. Natl. Acad. Sci. U. S. A. 109, 14870-14875. doi: 10.1073/pnas.1213333109
5. Bilguvar, K., Tyagi, N. K., Ozkara, C., Tuysuz, B., Bakircioglu, M., Choi, M., et al. (2013). Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 110, 3489-3494. doi: 10.1073/pnas.1222732110
6. Bingol, B., Tea, J. S., Phu, L., Reichelt, M., Bakalarski, C. E., Song, Q., et al. (2014). The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 509, 370-375. doi: 10.1038/nature13418
7. Blount, J. R., Burr, A. A., Denuc, A., Marfany, G., and Todi, S. V. (2012). Ubiquitin-specific protease 25 functions in endoplasmic reticulum-associated degradation. PLoS ONE 7: e36542. doi: 10.1371/journal.pone.0036542
8. Burnett, B., Li, F., and Pittman, R. N. (2003). The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 12, 3195-3205. doi: 10.1093/hmg/ddg344
9. Cadavid, A. L., Ginzel, A., and Fischer, J. A. (2000). The function of the Drosophila fat facets deubiquitinating enzyme in limiting photoreceptor cell number is intimately associated with endocytosis. Development 127, 1727-1736.
10. Cartier, A. E., Djakovic, S. N., Salehi, A., Wilson, S. M., Masliah, E., and Patrick, G. N. (2009). Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. J. Neurosci. 29, 7857-7868. doi: 10.1523/JNEUROSCI.1817-09.2009
11. Cemal, C. K., Carroll, C. J., Lawrence, L., Lowrie, M. B., Ruddle, P., Al-Mahdawi, S., et al. (2002). YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum. Mol. Genet. 11, 1075-1094. doi: 10.1093/hmg/11.9.1075
12. Chain, D. G., Hegde, A. N., Yamamoto, N., Liu-Marsh, B., and Schwartz, J. H. (1995). Persistent activation of cAMP-dependent protein kinase by regulated proteolysis suggests a neuron-specific function of the ubiquitin system in Aplysia. J. Neurosci. 15, 7592-7603.
13. Chen, F., Sugiura, Y., Myers, K. G., Liu, Y., and Lin, W. (2010). Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction. Proc. Natl. Acad. Sci. U. S. A. 107, 1636-1641. doi: 10.1073/pnas.0911516107
14. Chen, H., Polo, S., Di Fiore, P. P., and De Camilli, P. V. (2003). Rapid Ca2+-dependent decrease of protein ubiquitination at synapses. Proc. Natl. Acad. Sci. U. S. A. 100, 14908-14913. doi: 10.1073/pnas.2136625100
15. Chen, P. C., Bhattacharyya, B. J., Hanna, J., Minkel, H., Wilson, J. A., Finley, D., et al. (2011). Ubiquitin homeostasis is critical for synaptic development and function. J. Neurosci. 31, 17505-17513. doi: 10.1523/JNEUROSCI.2922-11.2011
16. Chen, P. C., Qin, L. N., Li, X. M., Walters, B. J., Wilson, J. A., Mei, L., et al. (2009). The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J. Neurosci. 29, 10909-10919. doi: 10.1523/JNEUROSCI.2635-09.2009
17. Chen, X., Zhang, B., and Fischer, J. A. (2002). A specific protein substrate for a deubiquitinating enzyme: liquid facets is the substrate of Fat facets. Genes Dev. 16, 289-294. doi: 10.1101/gad.961502
18. Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L. S., et al. (2004). Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279, 13256-13264. doi: 10.1074/jbc.M314124200
19. Clague, M. J., Barsukov, I., Coulson, J. M., Liu, H., Rigden, D. J., and Urbe, S. (2013). Deubiquitylases from genes to organism. Physiol. Rev. 93, 1289-1315. doi: 10.1152/physrev.00002.2013
20. Colland, F. (2010). The therapeutic potential of deubiquitinating enzyme inhibitors. Biochem. Soc. Trans. 38, 137-143. doi: 10.1042/BST0380137
21. Costa Mdo, C., and Paulson, H. L. (2012). Toward understanding Machado-Joseph disease. Prog. Neurobiol. 97, 239-257. doi: 10.1016/j.pneurobio.2011.11.006
22. Coulombe, J., Gamage, P., Gray, M. T., Zhang, M., Tang, M. Y., Woulfe, J., et al. (2014). Loss of UCHL1 promotes age-related degenerative changes in the enteric nervous system. Front. Aging Neurosci. 6: 129. doi: 10.3389/fnagi.2014.00129
23. D'Arcy, P., Brnjic, S., Olofsson, M. H., Fryknas, M., Lindsten, K., De Cesare, M., et al. (2011). Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med. 17, 1636-1640. doi: 10.1038/nm.2536
24. Das, C., Hoang, Q. Q., Kreinbring, C. A., Luchansky, S. J., Meray, R. K., Ray, S. S., et al. (2006). Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc. Natl. Acad. Sci. U. S. A. 103, 4675-4680. doi: 10.1073/pnas.0510403103
25. Diantonio, A., Haghighi, A. P., Portman, S. L., Lee, J. D., Amaranto, A. M., and Goodman, C. S. (2001). Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412, 449-452. doi: 10.1038/35086595
26. Doran, J. F., Jackson, P., Kynoch, P. A., and Thompson, R. J. (1983). Isolation of PGP 9. 5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J. Neurochem. 40, 1542-1547. doi: 10.1111/j.1471-4159.1983.tb08124.x
27. Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., et al. (2011). The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum. Mol. Genet. 20, 141-154. doi: 10.1093/hmg/ddq452
28. Fioravante, D., Liu, R. Y., and Byrne, J. H. (2008). The ubiquitin-proteasome system is necessary for long-term synaptic depression in aplysia. J. Neurosci. 28, 10245-10256. doi: 10.1523/JNEUROSCI.2139-08.2008
29. Fischer, J. A., and Overstreet, E. (2002). Fat facets does a Highwire act at the synapse. Bioessays 24, 13-16. doi: 10.1002/bies.10030
30. Fischer-Vize, J. A., Rubin, G. M., and Lehmann, R. (1992). The fat facets gene is required for Drosophila eye and embryo development. Development 116, 985-1000.
31. Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., et al. (2006). Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788. doi: 10.1016/j.cell.2006.06.046
32. Hanna, J., Hathaway, N. A., Tone, Y., Crosas, B., Elsasser, S., Kirkpatrick, D. S., et al. (2006). Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127, 99-111. doi: 10.1016/j.cell.2006.07.038
33. Hegde, A. N., Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain, D. G., et al. (1997). Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89, 115-126. doi: 10.1016/S0092-8674(00)80188-9
34. Heride, C., Urbe, S., and Clague, M. J. (2014). Ubiquitin code assembly and disassembly. Curr. Biol. 24, R215-220. doi: 10.1016/j.cub.2014.02.002
35. Hong, S., Kim, S. J., Ka, S., Choi, I., and Kang, S. (2002). USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Mol. Cell. Neurosci. 20, 298-306. doi: 10.1006/mcne.2002.1103
36. Huang, Y., Baker, R. T., and Fischer-Vize, J. A. (1995). Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene. Science 270, 1828-1831. doi: 10.1126/science.270.5243.1828
37. Huang, Z., Wu, Q., Guryanova, O. A., Cheng, L., Shou, W., Rich, J. N., et al. (2011). Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat. Cell Biol. 13, 142-152. doi: 10.1038/ncb2153
38. Hyrskyluoto, A., Bruelle, C., Lundh, S. H., Do, H. T., Kivinen, J., Rappou, E., et al. (2014). Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1alpha. Hum. Mol. Genet. doi: 10.1093/hmg/ddu317.[Epubaheadofprint].
39. Ishii, N., Owada, Y., Yamada, M., Miura, S., Murata, K., Asao, H., et al. (2001). Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice. Mol. Cell. Biol. 21, 8626-8637. doi: 10.1128/MCB.21.24.8626-8637.2001
40. Jackson, P., and Thompson, R. J. (1981). The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J. Neurol. Sci. 49, 429-438. doi: 10.1016/0022-510X(81)90032-0
41. Jin, L., Williamson, A., Banerjee, S., Philipp, I., and Rape, M. (2008). Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133, 653-665. doi: 10.1016/j.cell.2008.04.012
42. Jin, Y. N., Chen, P. C., Watson, J. A., Walters, B. J., Phillips, S. E., Green, K., et al. (2012). Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits. PLoS ONE 7: e47884. doi: 10.1371/journal.pone.0047884
43. Johnston, S. C., Riddle, S. M., Cohen, R. E., and Hill, C. P. (1999). Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J. 18, 3877-3887. doi: 10.1093/emboj/18.14.3877
44. Jung, H., Kim, B. G., Han, W. H., Lee, J. H., Cho, J. Y., Park, W. S., et al. (2013). Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling. Oncogenesis 2, e64. doi: 10.1038/oncsis.2013.28
45. Kim, H. J., Kim, H. J., Jeong, J. E., Baek, J. Y., Jeong, J., Kim, S., et al. (2014). N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage. PLoS ONE 9: e99654. doi: 10.1371/journal.pone.0099654
46. Kim, H. T., Kim, K. P., Lledias, F., Kisselev, A. F., Scaglione, K. M., Skowyra, D., et al. (2007). Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 282, 17375-17386. doi: 10.1074/jbc.M609659200
47. Kim, H. T., Kim, K. P., Uchiki, T., Gygi, S. P., and Goldberg, A. L. (2009). S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains. EMBO J. 28, 1867-1877. doi: 10.1038/emboj.2009.115
48. Knobeloch, K. P., Utermohlen, O., Kisser, A., Prinz, M., and Horak, I. (2005). Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 25, 11030-11034. doi: 10.1128/MCB.25.24.11030-11034.2005
49. Komander, D., and Rape, M. (2012). The ubiquitin code. Annu. Rev. Biochem. 81, 203-229. doi: 10.1146/annurev-biochem-060310-170328
50. Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., et al. (2011). Roles of HAUSP-mediated p53 regulation in central nervous system development. Cell Death Differ. 18, 1366-1375. doi: 10.1038/cdd.2011.12
51. Koulich, E., Li, X., and Demartino, G. N. (2008). Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol. Biol. Cell 19, 1072-1082. doi: 10.1091/mbc.E07-10-1040
52. Kowalski, J. R., Dahlberg, C. L., and Juo, P. (2011). The deubiquitinating enzyme USP-46 negatively regulates the degradation of glutamate receptors to control their abundance in the ventral nerve cord of Caenorhabditis elegans. J. Neurosci. 31, 1341-1354. doi: 10.1523/JNEUROSCI.4765-10.2011
53. Kowalski, J. R., and Juo, P. (2012). The role of deubiquitinating enzymes in synaptic function and nervous system diseases. Neural Plast. 2012: 892749. doi: 10.1155/2012/892749
54. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., et al. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108. doi: 10.1038/ng0298-106
55. Kurihara, L. J., Semenova, E., Levorse, J. M., and Tilghman, S. M. (2000). Expression and functional analysis of Uch-L3 during mouse development. Mol. Cell. Biol. 20, 2498-2504. doi: 10.1128/MCB.20.7.2498-2504.2000
56. Lam, Y. C., Bowman, A. B., Jafar-Nejad, P., Lim, J., Richman, R., Fryer, J. D., et al. (2006). ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 127, 1335-1347. doi: 10.1016/j.cell.2006.11.038
57. Lappe-Siefke, C., Loebrich, S., Hevers, W., Waidmann, O. B., Schweizer, M., Fehr, S., et al. (2009). The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice. PLoS Genet. 5: e1000631. doi: 10.1371/journal.pgen.1000631
58. Larsen, C. N., Krantz, B. A., and Wilkinson, K. D. (1998). Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37, 3358-3368. doi: 10.1021/bi972274d
59. Lee, B. H., Lee, M. J., Park, S., Oh, D. C., Elsasser, S., Chen, P. C., et al. (2010a). Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179-184. doi: 10.1038/nature09299
60. Lee, M. J., Lee, B. H., Hanna, J., King, R. W., and Finley, D. (2010b). Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell. Proteomics 10: R110. 003871. doi: 10.1074/mcp.R110.003871
61. Leroy, E., Anastasopoulos, D., Konitsiotis, S., Lavedan, C., and Polymeropoulos, M. H. (1998). Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. Hum. Genet. 103, 424-427. doi: 10.1007/s004390050845
62. Li, M., Brooks, C. L., Kon, N., and Gu, W. (2004). A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886. doi: 10.1016/S1097-2765(04)00157-1
63. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., et al. (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653. doi: 10.1038/nature737
64. Li, Y., Schrodi, S., Rowland, C., Tacey, K., Catanese, J., and Grupe, A. (2006). Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum. Mutat. 27, 1017-1023. doi: 10.1002/humu.20382
65. Liu, C. W., and Jacobson, A. D. (2013). Functions of the 19S complex in proteasomal degradation. Trends Biochem. Sci. 38, 103-110. doi: 10.1016/j.tibs.2012.11.009
66. Liu, N., Liu, C., Li, X., Liao, S., Song, W., Yang, C., et al. (2014). A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases. Sci. Rep. 4: 5240. doi: 10.1038/srep05240
67. Liu, Z., Meray, R. K., Grammatopoulos, T. N., Fredenburg, R. A., Cookson, M. R., Liu, Y., et al. (2009). Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 106, 4635-4640. doi: 10.1073/pnas.0806474106
68. Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., et al. (2014). REST and stress resistance in ageing and Alzheimer's disease. Nature 507, 448-454. doi: 10.1038/nature13163
69. Margolin, D. H., Kousi, M., Chan, Y. M., Lim, E. T., Schmahmann, J. D., Hadjivassiliou, M., et al. (2013). Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N. Engl. J. Med. 368, 1992-2003. doi: 10.1056/NEJMoa1215993
70. Marshall, A. G., Watson, J. A., Hallengren, J. J., Walters, B. J., Dobrunz, L. E., Francillon, L., et al. (2013). Genetic background alters the severity and onset of neuromuscular disease caused by the loss of ubiquitin-specific protease 14 (usp14). PLoS ONE 8: e84042. doi: 10.1371/journal.pone.0084042
71. Matos, C. A., De Macedo-Ribeiro, S., and Carvalho, A. L. (2011). Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog. Neurobiol. 95, 26-48. doi: 10.1016/j.pneurobio.2011.06.007
72. Mujtaba, T., and Dou, Q. P. (2011). Advances in the understanding of mechanisms and therapeutic use of bortezomib. Discov. Med. 12, 471-480.
73. Nathan, J. A., Kim, H. T., Ting, L., Gygi, S. P., and Goldberg, A. L. (2013). Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? EMBO J. 32, 552-565. doi: 10.1038/emboj.2012.354
74. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K., et al. (2005). A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786. doi: 10.1016/j.cell.2005.11.007
75. Nishikawa, K., Li, H., Kawamura, R., Osaka, H., Wang, Y. L., Hara, Y., et al. (2003). Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 304, 176-173. doi: 10.1016/S0006-291X(03)00555-2
76. Peth, A., Besche, H. C., and Goldberg, A. L. (2009). Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol. Cell 36, 794-804. doi: 10.1016/j.molcel.2009.11.015
77. Peth, A., Kukushkin, N., Bosse, M., and Goldberg, A. L. (2013a). Ubiquitinated proteins activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs. J. Biol. Chem. 288, 7781-7790. doi: 10.1074/jbc.M112.441907
78. Peth, A., Nathan, J. A., and Goldberg, A. L. (2013b). The ATP costs and time required to degrade ubiquitinated proteins by the 26 S proteasome. J. Biol. Chem. 288, 29215-29222. doi: 10.1074/jbc.M113.482570
79. Peth, A., Uchiki, T., and Goldberg, A. L. (2010). ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation. Mol. Cell 40, 671-681. doi: 10.1016/j.molcel.2010.11.002
80. Qiu, X. B., Ouyang, S. Y., Li, C. J., Miao, S., Wang, L., and Goldberg, A. L. (2006). hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J. 25, 5742-5753. doi: 10.1038/sj.emboj.7601450
81. Reina, C. P., Nabet, B. Y., Young, P. D., and Pittman, R. N. (2012). Basal and stress-induced Hsp70 are modulated by ataxin-3. Cell Stress Chaperones 19, 235-249. doi: 10.1007/s12192-012-0346-2
82. Reina, C. P., Zhong, X., and Pittman, R. N. (2010). Proteotoxic stress increases nuclear localization of ataxin-3. Hum. Mol. Genet. 19, 235-249. doi: 10.1093/hmg/ddp482
83. Reyes-Turcu, F. E., Ventii, K. H., and Wilkinson, K. D. (2009). Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397. doi: 10.1146/annurev.biochem.78.082307.091526
84. Ritchie, K. J., Malakhov, M. P., Hetherington, C. J., Zhou, L., Little, M. T., Malakhova, O. A., et al. (2002). Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16, 2207-2212. doi: 10.1101/gad.1010202
85. Rivkin, E., Almeida, S. M., Ceccarelli, D. F., Juang, Y. C., Maclean, T. A., Srikumar, T., et al. (2013). The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 498, 318-324. doi: 10.1038/nature12296
86. Rott, R., Szargel, R., Haskin, J., Bandopadhyay, R., Lees, A. J., Shani, V., et al. (2011). alpha-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc. Natl. Acad. Sci. U. S. A. 108, 18666-18671. doi: 10.1073/pnas.1105725108
87. Saigoh, K., Wang, Y. L., Suh, J. G., Yamanishi, T., Sakai, Y., Kiyosawa, H., et al. (1999). Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23, 47-51. doi: 10.1038/12647
88. Saliba, R. S., Michels, G., Jacob, T. C., Pangalos, M. N., and Moss, S. J. (2007). Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites. J. Neurosci. 27, 13341-13351. doi: 10.1523/JNEUROSCI.3277-07.2007
89. Sano, Y., Furuta, A., Setsuie, R., Kikuchi, H., Wang, Y. L., Sakurai, M., et al. (2006). Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice. Am. J. Pathol. 169, 132-141. doi: 10.2353/ajpath.2006.060085
90. Scaglione, K. M., Zavodszky, E., Todi, S. V., Patury, S., Xu, P., Rodriguez-Lebron, E., et al. (2011). Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 43, 599-612. doi: 10.1016/j.molcel.2011.05.036
91. Schmitt, I., Linden, M., Khazneh, H., Evert, B. O., Breuer, P., Klockgether, T., et al. (2007). Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem. Biophys. Res. Commun. 362, 734-739. doi: 10.1016/j.bbrc.2007.08.062
92. Scoma, H. D., Humby, M., Yadav, G., Zhang, Q., Fogerty, J., and Besharse, J. C. (2011). The de-ubiquitinylating enzyme, USP2, is associated with the circadian clockwork and regulates its sensitivity to light. PLoS ONE 6: e25382. doi: 10.1371/journal.pone.0025382
93. Setsuie, R., and Wada, K. (2007). The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 51, 105-111. doi: 10.1016/j.neuint.2007.05.007
94. Setsuie, R., Wang, Y. L., Mochizuki, H., Osaka, H., Hayakawa, H., Ixhihara, N., et al. (2007). Dopaminaergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 50, 119-129. doi: 10.1016/j.neuint.2006.07.015
95. Sowa, M. E., Bennett, E. J., Gygi, S. P., and Harper, J. W. (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403. doi: 10.1016/j.cell.2009.04.042
96. Staropoli, J. F., and Abeliovich, A. (2005). The ubiquitin-proteasome pathway is necessary for maintenance of the postmitotic status of neurons. J. Mol. Neurosci. 27, 175-183. doi: 10.1385/JMN:27:2:175
97. Suzuki, S., Tamai, K., Watanabe, M., Kyuuma, M., Ono, M., Sugamura, K., et al. (2011). AMSH is required to degrade ubiquitinated proteins in the central nervous system. Biochem. Biophys. Res. Commun. 408, 582-588. doi: 10.1016/j.bbrc.2011.04.065
98. Switonski, P. M., Fiszer, A., Kazmierska, K., Kurpisz, M., Krzyzosiak, W. J., and Figiel, M. (2011). Mouse ataxin-3 functional knock-out model. Neuromol. Med. 13, 54-65. doi: 10.1007/s12017-010-8137-3
99. Tai, H. C., Besche, H., Goldberg, A. L., and Schuman, E. M. (2010). Characterization of the brain 26S proteasome and its interacting proteins. Front Mol Neurosci 3: 12. doi: 10.3389/fnmol.2010.00012
100. Tan, E. K., and Skipper, L. M. (2007). Pathogenic mutations in Parkinson disease. Hum. Mutat. 28, 641-653. doi: 10.1002/humu.20507
101. Tao, B. B., He, H., Shi, X. H., Wang, C. L., Li, W. Q., Li, B., et al. (2013). Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade. J. Clin. Neurosci. 20, 717-720. doi: 10.1016/j.jocn.2012.03.050
102. Thrower, J. S., Hoffman, L., Rechsteiner, M., and Pickart, C. M. (2000). Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102. doi: 10.1093/emboj/19.1.94
103. Todi, S., and Das, C. (2012). Should deubiquitinating enzymes be targeted for therapy? Clin. Pharmacol. Biopharm. 1, 2. doi: 10.4172/2167-065X.1000e108
104. Todi, S. V., and Paulson, H. L. (2011). Balancing act: deubiquitinating enzymes in the nervous system. Trends Neurosci. 34, 370-382. doi: 10.1016/j.tins.2011.05.004
105. Todi, S. V., Williams, A., and Paulson, H. (2007). "Polyglutamine repeat disorders, including Huntington's disease, " in Molecular Neurology, 1 Edn., ed S. G. Waxman (London: Academic Press), 257-276.
106. Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., and Paulson, H. L. (2009). Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J. 28, 372-382. doi: 10.1038/emboj.2008.289
107. Tomida, S., Mamiya, T., Sakamaki, H., Miura, M., Aosaki, T., Masuda, M., et al. (2009). Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests. Nat. Genet. 41, 688-695. doi: 10.1038/ng.344
108. Tsou, W.-L., Burr, A. A., Ouyang, M., Blount, J. R., Scaglione, K. M., and Todi, S. V. (2013). Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 In vivo. J. Biol. Chem. 92, 1100-1109. doi: 10.1074/jbc.M113.513903
109. Tsou, W.-L., Sheedlo, M. J., Morrow, M. E., Blount, J. R., McGregor, K. M., Das, C., et al. (2012). Systematic analysis of the physiological importance of deubiquitinating enzymes. PLoS ONE 7: e43112. doi: 10.1371/journal.pone.0043112
110. Valero, R., Marfany, G., Gonzalez-Angulo, O., Gonzalez-Gonzalez, G., Puelles, L., and Gonzalez-Duarte, R. (1999). USP25, a novel gene encoding a deubiquitinating enzyme, is located in the gene-poor region 21q11. 2. Genomics 62, 395-405. doi: 10.1006/geno.1999.6025
111. Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R. 3rd. Koonin, E. V., et al. (2002). Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298, 611-615. doi: 10.1126/science.1075898
112. Walters, B. J., Campbell, S. L., Chen, P. C., Taylor, A. P., Schroeder, D. G., Dobrunz, L. E., et al. (2008). Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity. Mol. Cell. Neurosci. 39, 539-548. doi: 10.1016/j.mcn.2008.07.028
113. Wang, Q., Li, L., and Ye, Y. (2006). Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J. Cell Biol. 174, 963-971. doi: 10.1083/jcb.200605100
114. Warrick, J. M., Morabito, L. M., Bilen, J., Gordesky-Gold, B., Faust, L. Z., Paulson, H. L., et al. (2005). Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell 18, 37-48. doi: 10.1016/j.molcel.2005.02.030
115. Wicks, S. J., Haros, K., Maillard, M., Song, L., Cohen, R. E., Dijke, P. T., et al. (2005). The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24, 8080-8084. doi: 10.1038/sj.onc.1208944
116. Wilkinson, K. D., Deshpande, S., and Larsen, C. N. (1992). Comparisons of neuronal (PGP 9. 5) and non-neuronal ubiquitin C-terminal hydrolases. Biochem. Soc. Trans. 20, 631-637.
117. Williams, A. J., and Paulson, H. L. (2008). Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 31, 521-528. doi: 10.1016/j.tins.2008.07.004
118. Wilson, S. M., Bhattacharyya, B., Rachel, R. A., Coppola, V., Tessarollo, L., Householder, D. B., et al. (2002). Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat. Genet. 32, 420-425. doi: 10.1038/ng1006
119. Winborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., et al. (2008). The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits K63-linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 283, 26436-26443. doi: 10.1074/jbc.M803692200
120. Wood, M. A., Kaplan, M. P., Brensinger, C. M., Guo, W., and Abel, T. (2005). Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory. Hippocampus 15, 610-621. doi: 10.1002/hipo.20082
121. Xia, Q., Liao, L., Cheng, D., Duong, D. M., Gearing, M., Lah, J. J., et al. (2008). Proteomic identification of novel proteins associated with Lewy bodies. Front. Biosci. 13, 3850-3856. doi: 10.2741/2973
122. Yao, T., and Cohen, R. E. (2002). A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419, 403-407. doi: 10.1038/nature01071
123. Yao, T., Song, L., Xu, W., Demartino, G. N., Florens, L., Swanson, S. K., et al. (2006). Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat. Cell Biol. 8, 994-1002. doi: 10.1038/ncb1460
124. Yi, J. J., and Ehlers, M. D. (2007). Emerging roles for ubiquitin and protein degradation in neuronal function. Pharmacol. Rev. 59, 14-39. doi: 10.1124/pr.59.1.4
125. Yuasa-Kawada, J., Kinoshita-Kawada, M., Wu, G., Rao, Y., and Wu, J. Y. (2009). Midline crossing and Slit responsiveness of commissural axons require USP33. Nat. Neurosci. 12, 1087-1089. doi: 10.1038/nn.2382
126. Zeng, L., Tallaksen-Greene, S. J., Wang, B., Albin, R. L., and Paulson, H. L. (2013). The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease. J. Huntingtons. Dis. 2, 201-215. doi: 10.3233/JHD-130058
127. Zhang, M., Deng, Y., Luo, Y., Zhang, S., Zou, H., Cai, F., et al. (2012). Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. J. Neurochem. 120, 1129-1138. doi: 10.1111/j.1471-4159.2011.07644.x
128. Zhang, X., Zhou, J. Y., Chin, M. H., Schepmoes, A. A., Petyuk, V. A., Weitz, K. K., et al. (2010). Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model. J. Proteome Res. 9, 1496-1509. doi: 10.1021/pr901024z
129. Zhao, Z. B., Wu, L., Xiong, R., Wang, L. L., Zhang, B., Wang, C., et al. (2014). MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease. Neuroscience 275C, 232-237. doi: 10.1016/j.neuroscience.2014.06.013
130. Zhong, X., and Pittman, R. N. (2006). Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet. 15, 2409-2420. doi: 10.1093/hmg/ddl164